Clinical Trial

Cerebellar Modulation of Cognition in Psychosis

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn about cognition in psychotic disorders (schizophrenia, bipolar disorder, and schizoaffective disorder). The main question it aims to answer is: Can we use magnetic stimulation to change processing speed (how quickly people can solve challenging tasks). Participants will be asked to perform cognitive tasks (problem-solving) and undergo brain scans before and after transcranial magnetic stimulation (TMS). TMS is a way to non-invasively change brain activity. Forms of TMS are FDA-approved to treat depression and obsessive compulsive disorder. In this study, we will use a different form of TMS to temporarily change brain activity to observe how that changes speed in problem-solving.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-24; most recent amendment 2026-03-16.
Status change: Not Yet Recruiting → Recruiting 2024-08-05
Trial Details
NCT Number NCT06107764
Lead Sponsor Mclean Hospital
Collaborators: Beth Israel Deaconess Medical Center
Conditions Schizophrenia, Schizoaffective Disorder, Bipolar Disorder I, Psychosis
Enrollment 95 participants
Start Date 2024-07-31
Primary Completion 2029-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-17